Velico Medical

Beverly, MA · Founded 1992 · Privately Held (backing)

Developer of pre-clinical medical technology committed to reducing preventable death from bleeding. Velico Medical is based in Beverly, MA and was founded in 1992.

Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—

Velico Medical key facts

  • Developer of pre-clinical medical technology committed to reducing preventable death from bleeding.
  • Notable investors include New York Angels, Rosetta Capital (UK).
  • Status: Privately Held (backing).

Who backs Velico Medical

2
Free account
More of Velico Medical with a free account
  • ·Watch Velico Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Velico Medical funding rounds

No rounds on record

No funding rounds for Velico Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Velico Medical investors

2 investors are on record for Velico Medical, including New York Angels and Rosetta Capital (UK). By type, the record holds 1 venture capital firm and 1 angel investor.

About Velico Medical

Developer of pre-clinical medical technology committed to reducing preventable death from bleeding. The company engages in developing a novel, dry plasma manufacturing system, thereby helping blood centers to produce point-of-care, dry plasma products for transfusion.

Sector
Healthcare
HQ
Beverly, MA, United States
Founded
1992
Employees
46
Website
veli.co/
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation — not yet priced

Velico Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.